Company Filing History:

19 out of 200

Pharmacia Corporation

patents

12 out of 1,323

G.d. Searle & Company

Pharmacia Corporation Global Patent Department

patent

Years Active: 2002-2010

Loading Chart...

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),

2. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),

3. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),

4. 6906068 - Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants (2005-06-14),

5. 6867217 - Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade (2005-03-15),

6. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),

7. 6765023 - Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-07-20),

8. 6750342 - Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade (2004-06-15),

9. 6723753 - Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

10. 6723752 - (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

11. 6710089 - Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-23),

12. 6699898 - Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-02),

13. 6696472 - Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

14. 6696435 - Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

15. 6683113 - (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-01-27),

Title: The Innovative Journey of Inventor Ashton T Hamme

Introduction:

Ashton T Hamme, a distinguished inventor based in St. Louis, MO (US), has left an indelible mark on the world of pharmaceuticals with his remarkable contributions. With an impressive portfolio of 37 patents under his name, Hamme's work has revolutionized the field of medicinal chemistry.

Latest Patents:

One of his groundbreaking inventions includes the development of (R)-chiral halogenated substituted fused heterocyclic amino compounds. These compounds have shown promising potential in inhibiting cholesterol ester transfer protein activity, thereby offering new avenues for the treatment of atherosclerosis and coronary artery diseases. Hamme's innovative processes for the preparation of these compounds have significantly enhanced their yield and stereoselectivity.

Career Highlights:

Throughout his career, Ashton T Hamme has made significant contributions to renowned companies such as Pharmacia Corporation and G.D. Searle & Company. His expertise and ingenuity have played a pivotal role in advancing the pharmaceutical industry and bringing forth novel therapeutic solutions.

Collaborations:

An inventor of Hamme's caliber does not work in isolation. He has collaborated with esteemed colleagues such as Melvin L Rueppel and Richard C Durley, whose collective efforts have led to the successful development and implementation of cutting-edge pharmaceutical technologies.

Conclusion:

In conclusion, Ashton T Hamme stands as a testament to the power of innovation and perseverance in the realm of medicinal chemistry. His relentless pursuit of excellence and unwavering commitment to scientific advancement continue to inspire generations of inventors and researchers worldwide. Hamme's legacy will undoubtedly endure as a beacon of innovation in the ever-evolving landscape of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com